FDA Approved: RITUXAN HYCELA — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Rituxan Hycela (rituximab and hyaluronidase) by Genentech, updating the labeling for this subcutaneous rituximab pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis
• Non-hodgkin Lymphoma
• Rheumatoid Arthritis
• Small Lymphocytic Lymphoma

Drugs mentioned

• Rituxan Hycela (rituximab/hyaluronidase)

Snippet

SUPPL AP for RITUXAN HYCELA (RITUXIMAB AND HYALURONIDASE)